Novartis Profile

Performance

1616
   

Odds of Distress

14%14%
Check how we calculate scores
Equity ratings for Novartis AG are calculated based on Macroaxis scoring framework. The performance scores are derived for the period starting May 22, 2019 and ending today July 21, 2019. Click here to learn more.
93.56
USD 0.7  0.74%

Novartis Summary

Novartis AG (NVS) is traded on BATS Exchange in USA. It is located in Lichtstrasse 35 and employs 105,000 people. Novartis AG was previously known as Novartis AG and was traded on BATS Exchange under the symbol NVSEF. Novartis is listed under Pharmaceutical Products category by Fama And French industry classification. The company currently falls under 'Mega-Cap' category with total capitalization of 207.6B. Novartis AG runs under Healthcare sector within Drug Manufacturers - Major industry. The entity has 2.29B outstanding shares of which 4.15M shares are now shorted by investors with about 2.02 days to cover shorted positions. NOVARTIS AG ADS has about 7.05B in cash with 22.3B of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 3.03.
Check Novartis Probability Of Bankruptcy

Ownership Allocation (%)

Novartis Target Price Odds Analysis

Odds Below 93.56HorizonTargetOdds Above 93.56
92.31%30 days 93.56 7.57%
Based on normal probability distribution, the odds of Novartis to move above current price in 30 days from now is about 7.57% (This Novartis AG probability density function shows the probability of Novartis Stock to fall within a particular range of prices over 30 days) .

Novartis AG Top Holders

Novartis Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Country Trust BankCommon Shares359.8 K32.9 M
Douglas Lane Associates LlcCommon Shares343.2 K31.3 M
View Novartis Diagnostics

Novartis AG Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Novartis Key Fundamentals

Novartis Against Markets

Novartis Vital Trading Data

Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company was founded in 1895 and is headquartered in Basel, Switzerland. Novartis operates under Drug Manufacturers - Major classification in USA and is traded on BATS Exchange. It employs 105000 people. more
Fama & French Pharmaceutical Products
Pharmaceutical Products
Fama & French Classification
Novartis AG SEC Filings
Novartis SEC Filings
Security & Exchange Commission EDGAR ReportsView All
NameNovartis AG
President CEOChris IlsleyView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Drug Manufacturers - Major
InstrumentUSA Stock View All
LocationSwitzerland
Business AddressLichtstrasse 35
Foreign Associate  Argentina
ExchangeBATS Exchange
CUSIP66987V109
Prior SymbolNVSEF
SectorHealthcare
IndustryDrug Manufacturers - Major
BenchmarkDOW
Websitewww.novartis.com
Phone41 61 324 1111
CurrencyUSD - US Dollar
Next Fiscal Year EndDecember 31, 2020
Most Recent QuarterMarch 31, 2019
Last Fiscal Year EndDecember 31, 2018
Date Short InterestJune 28, 2019

Novartis Corporate Directors

Ton Buechner Non-Executive Independent Director
Pierre Landolt Member of the Board of Directors
Elizabeth Doherty Non-Executive Independent Director
Please see also Stocks Correlation. Please also try Financial Widgets module to easily integrated macroaxis content with over 30 different plug-and-play financial widgets.
Search macroaxis.com